{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-070964","form_type":"8-K","ticker":"OM","cik":"0001484612","company_name":"Outset Medical, Inc.","filed_at":"2025-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.424520+00:00","generated_at":"2026-05-21T08:24:09.603942+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Outset Medical appoints Kevin O'Boyle to board, Dale Jones resigns","bullets":["Dale E. Jones stepped down from the Board effective May 14, 2025; no disagreement with company.","Kevin O'Boyle appointed as director and Audit Committee Chair, effective May 14, 2025.","O'Boyle brings over 20 years healthcare leadership; former CFO of NuVasive and Advanced Biohealing.","Patrick Hackett transitions from Audit Committee Chair; Andrea Saia moves to Compensation Committee.","D. Keith Grossman appointed Compensation Committee Chair; committee changes effective May 14, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-070964","json":"https://secwatch.observer/filing/0000950170-25-070964.json","markdown":"https://secwatch.observer/filing/0000950170-25-070964.md","text":"https://secwatch.observer/filing/0000950170-25-070964.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484612/000095017025070964/0000950170-25-070964-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484612/000095017025070964/om-20250510.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T08:24:09.603942+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4f9fbfa29b","claim":"Kevin O'Boyle was appointed as new member of the Board and as a member and Chair of the Audit Committee at Outset Medical, Inc..","evidence_excerpt":"On May 12, 2025, the Board appointed Kevin O’Boyle as a new member of the Board and as a member and Chair of the Audit Committee of the Board, with such appointment effective May 14, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484612/000095017025070964/0000950170-25-070964-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"new member of the Board and as a member and Chair of the Audit Committee"}],"fact_type":"executive_change"},{"claim_id":"f22d804d7a","claim":"Dale E. Jones departed as member of the Board of Directors at Outset Medical, Inc..","evidence_excerpt":"On May 10, 2025, Dale E. Jones, a member of the Board of Directors (the “Board”) of Outset Medical, Inc. (the “Company”), stepped down from the Board, effective May 14, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484612/000095017025070964/0000950170-25-070964-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}